Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Convertible Notes Payable, Current

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Convertible Notes Payable, Current

Citius Pharmaceuticals, Inc. (CTXR) had Convertible Notes Payable, Current of $100.00 thousand as of 2016-12-14, per its 10-K filed 2016-12-23.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities

us-gaap:ConvertibleNotesPayableCurrent · last filed 2016-12-23

  • 2016-12-14: Convertible Notes Payable, Current $100.00K.
  • 2016-12-09: Convertible Notes Payable, Current $500.00K.
  • 2016-10-20: Convertible Notes Payable, Current $500.00K.
Period endConvertible Notes Payable, Current
2016-12-14$100.00K
10-K · filed 2016-12-23
2016-12-09$500.00K
10-K · filed 2016-12-23
2016-10-20$500.00K
10-K · filed 2016-12-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36